Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pre-mRNA Processing: RNA Splicing01:32

Pre-mRNA Processing: RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative analysis of drug-gene signatures in human pluripotent stem cells reveals prazosin as a novel SQSTM1 regulator for ALS therapeutics.

Stem cell reports·2026
Same author

MYCN and helicases DDX17 and DDX5 have opposite effects on the production of readthrough-associated chimeric transcripts.

Cellular and molecular life sciences : CMLS·2026
Same author

Identification of microprotein-coding intronic polyadenylation isoforms and function in genotoxic anticancer drug response.

Genome biology·2025
Same author

RNA at the crossroads of structure, function, and disease.

Biochimie·2025
Same author

Alternative splicing in the RBMXL1 5'-UTR induces uORF-mediated translation control in activated B lymphocytes.

Scientific reports·2025
Same author

Post-transcriptional gene regulation: From mechanisms to RNA chemistry and therapeutics.

Bulletin du cancer·2024
Same journal

Position-Dependent Stabilization of DNA/RNA Duplexes by Site-Specific Incorporation of LNA Nucleosides.

Journal of nucleic acids·2026
Same journal

RETRACTION: Genetic Clearness Novel Strategy of Group I <i>Bacillus</i> Species Isolated from Fermented Food and Beverages by Using Fibrinolytic Enzyme Gene Encoding a Serine-Like Enzyme.

Journal of nucleic acids·2026
Same journal

A Biochemical Analysis of LINC00896 RNA in Cortex Neuronal Cells and Its Possible Connection to the Development of Autism.

Journal of nucleic acids·2026
Same journal

Corrigendum to "Design and Evaluation of RNA Aptamer-Mediated Delivery of C/EBP<i>β</i> siRNA for Oncological Therapy".

Journal of nucleic acids·2025
Same journal

Design and Evaluation of RNA Aptamer-Mediated Delivery of C/EBP<i>β</i> siRNA for Oncological Therapy.

Journal of nucleic acids·2025
Same journal

Dual Detection of Hepatitis B and C Viruses Using CRISPR-Cas Systems and Lateral Flow Assay.

Journal of nucleic acids·2024
See all related articles

Related Experiment Video

Updated: May 27, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Splicing programs and cancer.

Sophie Germann1, Lise Gratadou, Martin Dutertre

  • 1Université de Lyon, 28 rue Laënnec, 69008 Lyon, France.

Journal of Nucleic Acids
|December 2, 2011
PubMed
Summary
This summary is machine-generated.

Alternative splicing alterations are increasingly recognized in cancer. Large-scale analyses reveal these changes impact key cellular networks, offering new therapeutic targets for cancer initiation and progression.

More Related Videos

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

Related Experiment Videos

Last Updated: May 27, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gene-by-gene analysis has identified splicing alterations in various cancers.
  • Novel technologies enable large-scale analysis of alternative splicing in cancer.

Purpose of the Study:

  • To explore the role of alternative splicing in cancer at a large scale.
  • To understand how splicing alterations contribute to cancer initiation and progression.
  • To identify splicing factors regulating cancer-associated splicing programs.

Main Methods:

  • Genome-wide analyses of alternative splicing.
  • Identification of misregulated splicing variants in cancer.
  • Studies on splicing factors controlling cancer-associated splicing programs.

Main Results:

  • Alternative splicing alterations affect gene networks crucial for cellular programs.
  • Many cancer-associated splicing variants are also present in normal tissues.
  • Splicing factors have been identified that control cancer-associated splicing programs.

Conclusions:

  • Splicing programs are altered during cancer initiation and progression.
  • Characterizing splicing programs and their regulation is key to understanding cancer genetics.
  • Splicing factors and programs represent potential therapeutic targets for cancer treatment.